2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone has been researched along with Fragile X Syndrome in 1 studies
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone: ubiquinol analog
6-decylubiquinone : A member of the class of 1,4-benzoquinones that is 2,3-dimethoxybenzoquinone which has been substituted at positions 5 and 6 by decyl and methyl groups.
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barajas, M | 1 |
| Wang, A | 1 |
| Griffiths, KK | 1 |
| Matsumoto, K | 1 |
| Liu, R | 1 |
| Homma, S | 1 |
| Levy, RJ | 1 |
1 other study available for 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Fragile X Syndrome
| Article | Year |
|---|---|
The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart.
Topics: Animals; Atractyloside; Cyclosporine; Disease Models, Animal; Electron Transport; Fetal Heart; Fragi | 2021 |